Quantification of Diclofenac 2.32% (Voltaren) in Rinse Water After Different Application Methods
← catalyst calendarSponsored by HALEON (industry) · HLN — their whole pipeline →.
Phase
Not applicable
Status
Completed
Study type
Interventional
Design
Non randomized · None · Other
Enrollment
33actual
Sites
1
Country
Germany
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-03-26 | actual | When the study began enrolling |
| Primary completion | 2025-04-11 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-04-11 | actual | The whole study's end, after follow-up |
| First posted | 2025-05-01 | actual | When this record first appeared on the registry |
| Results posted | 2026-06-16 | actual | When the sponsor posted results to the registry |
| Record updated | 2026-06-16 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Healthy Participants
Intervention
- Drug: Voltaren® Schmerzgel forte; 2.32% (Test Product)
Primary outcomes
what the primary-completion date above is the date OFConcentration of Voltaren® Schmerzgel Forte; 2.32% (Diclofenac) in Water (Milligrams Per Liter [mg/L]) After Washing
measured Day 1, Day 3 and Day 5
Amount of Test Product Residues by Gravimetrical Measurements (in Gram)
measured Day 1, Day 3 and Day 5
Posted documents
hosted by the registry — we link, never re-serveStudy Protocol and Statistical Analysis Planposted 2025-03-06 · 1.1 MB · Prot_SAP_000.pdf
Permalink · HLN's whole pipeline · Catalyst calendar · Every registered study · What changed